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lenses, as shown also in the Table. Dose values are smaller 
(Dmax 16.7%, i.e. around 6 Gy) than those reported in other 
studies. In our case, the opposed-lateral setup is associated 
to larger lens doses (56.6%) than those reported using the 
same technique in another study (26.4%), suggesting that our 
specific case was a difficult one, presumably age-related. 
 
 
 
 
 
Conclusion: The beam arrangement we applied allowed both 
an optimal coverage of the cribriform plate and lens sparing. 
The low maximal dose to the lenses might reduce the risk of 
radiation-associated cataract. 
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Purpose or Objective: To evaluate the incidental testicular 
during prostate radiation therapy with intensity-modulated 
radiotherapy (IMRT) and volumetric-modulated arc 
radiotherapy (VMAT) at different energies. 
 
Material and Methods: Dosimetric data of 15 intermediate-
risk prostate cancer patients treated with radiotherapy was 
analyzed. The prescribed dose was 78 Gy in 39 fractions. 
Dosimetric analysis compared testicular doses generated by 
7-field IMRT and VMAT with a single arc at 6, 10, and 15MV 
energy levels. Doses from the treatment planning system 
were verified with metal-oxide-semiconductor field-effect 
transistor detectors. Detectors were placed within a solid, 
flat phantom at 10 cm depth, from the center of the 
irradiated field out to 30 cm, with 2 cm distances and 1 cm 
depth for scattered doses. Values measured from the 
treatment planning system were compared with values from 
the detectors. 
 
Results: The mean distance between center of the prostate 
and the testes was 13.5±1.4 cm (range, 11.6-16.8 cm). For a 
complete course of 39 fractions, mean testicular doses from 
the IMRT and VMAT measured in the treatment planning 
system were 16.3±10.3 cGy vs. 21.5±11.2 cGy (p=0.03) at 6 
MV, 13.4±10.4 cGy vs. 17.8±10.7 cGy (p=0.04) at 10 MV, and 
10.6±8.5 cGy vs. 14.5±8.6 cGy (p=0.03) at 15 MV, 
respectively. Mean scattered testicular doses in the phantom 
measurements were 99.5±17.2 cGy, 118.7±16.4 cGy, and 
193.9±14.5 cGy at 6, 10, and 15 MV, respectively, in the IMRT 
plans. In the VMAT plans, corresponding testicular doses were 
90.4±16.3 cGy, 103.6±16.4 cGy, and 139.3±14.6 cGy at 6, 10, 
and 15 MV, respectively. The scattered testicular doses were 
significantly higher in the IMRT versus the VMAT plans. 
 
Conclusion: Testicular doses during radiotherapy were high 
enough potentially to impair the endocrine function of Leydig 
cells. Higher photon energy and IMRT plans resulted in higher 
incidental testicular doses compared to lower photon energy 
and VMAT plans. 
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Purpose or Objective: Constant dose rate VMAT (CDR-VMAT) 
introduces rotational arc radiotherapy for linacs incapable of 
dose rate variation. The goal of this study was to evaluate 
CDR-VMAT adequacy for the treatment of head and neck 
(H&N) cancer compared to Step-and-Shoot IMRT. 
 
Material and Methods: Ten patients (five with oropharyngeal 
cancer -OPC- and five with hypopharyngeal cancer -HPC-) 
were enrolled in this study. For each patient, were defined 
three PTVs: PTV66Gy, PTV60Gy and PTV54Gy with a dose 
prescription of 66 Gy, 60 Gy and 54 Gy all delivered in 30 
fractions. OARs included mandible, spinal cord, brain stem, 
parotids, salivary glands, esophagus, larynx and thyroid . All 
patients were previously treated using step and shoot IMRT 
with seven 6 MV coplanar beams. A protocol for CDR-VMAT 
plans which consisted of two arcs was established: first arc 
with start angle was of 182° and a stop angle of 178° in a 
clockwise direction; the second one in a counterclockwise 
direction from 178° to 182°; the final arc spacing was set to 
4 degree and collimator angle to 45°. For each patient, a 
CDR- VMAT plan was generated according to this protocol. A 
dose rate of 300 MU/minute was selected for both IMRT and 
CDR-VMAT plans. All plans were performed with Pinnacle3 
treatment planning system (v 9.8) with identical dose 
constraints to OARs and dose prescription to targets; it was 
required that PTVs D95% be 95% of prescribed dose and OARs 
be spared as more as possible.Dose distributions were 
compared by evaluating PTVs’ Dmean, D2%, D50%, D98% and 
Homogeneity Index (HI) defined as 
 
 
